ABASAGLAR

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Lithuania, Netherlands, Poland, Romania, United Kingdom

Active ingredients

The drug ABASAGLAR contains one active pharmaceutical ingredient (API):

1 Insulin glargine UNII 2ZM8CX04RZ - INSULIN GLARGINE

Insulin glargine is a human insulin analogue designed to have a low solubility at neutral pH. After injection, the acidic solution is neutralised leading to formation of a precipitate from which small amounts of insulin glargine are continuously released. Read about Insulin glargine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10AE04	Insulin glargine	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AE Insulins and analogues for injection, long-acting
Discover more medicines within A10AE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1664906, 1664917, 1664928, 1664939, 1665031, 1665042, 1665053, 1665064, 1856134, 1856145
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 114944012
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 138421, 448060, 451991
Country: FR	Base de données publique des médicaments	Identifier(s): 64332894, 66513085
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 301720, 301724
Country: IE	Health Products Regulatory Authority	Identifier(s): 69486
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1074462, 1074466, 1074467, 1080467, 1080470, 1080471, 1091116, 1091117
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 121312
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100332006
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65160002, W65161001